Información bibliográfica

GuíaWHO recommendations on the management of sickle cell disease during pregnancy, childbirth and the interpregnancy period
Año de publicación2025
Institución emisoraWorld Health Organization

Recomendación

Nueva

For pregnant women with sickle-cell disease (SCD) (not hospitalized), consider additional risk factors for thromboembolism (e.g. prior venous thromboembolism (VTE) following vaso-occlusive events) and follow local recommendations for initiation of thromboprophylaxis for pregnant women with elevated risk of thrombotic events (e.g. prior VTE, obesity, inherited thrombophilia).

Recomendado